We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$42.2B
AUM Growth
-$1.23B
Cap. Flow
-$952M
Cap. Flow %
-2.26%
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$156M
2
PLD icon
Prologis
PLD
+$150M
3
CVX icon
Chevron
CVX
+$109M
4
QCOM icon
Qualcomm
QCOM
+$101M
5
PAYC icon
Paycom
PAYC
+$90.8M

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Healthcare 17.11%
3 Financials 12.73%
4 Industrials 9.92%
5 Consumer Discretionary 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
101
Vertex Pharmaceuticals
VRTX
$125B
$99.2M 0.24%
211,642
-273
-0.1% -$118K
INTU icon
102
Intuit
INTU
$89.3B
$98.9M 0.23%
150,473
+23,201
+18% +$14.4M
NNN icon
103
NNN REIT
NNN
$9.39B
$98.9M 0.23%
2,321,107
-85,542
-4% -$3.56M
KVUE icon
104
Kenvue
KVUE
$37.7B
$98.3M 0.23%
5,408,819
-541,513
-9% -$10.5M
CAVA icon
105
CAVA Group
CAVA
$7.55B
$98.3M 0.23%
1,060,029
+93,635
+10% +$7.23M
GPCR icon
106
Structure Therapeutics
GPCR
$3.38B
$94.5M 0.22%
2,407,206
+150,000
+7% +$6.16M
ATI icon
107
ATI
ATI
$24.5B
$94.4M 0.22%
1,702,648
+70,812
+4% +$3.97M
JPM icon
108
JPMorgan Chase
JPM
$931B
$94.3M 0.22%
466,259
-158,567
-25% -$31M
CM icon
109
Canadian Imperial Bank of Commerce
CM
$107B
$93.3M 0.22%
1,961,978
-74,810
-4% -$3.63M
PEP icon
110
PepsiCo
PEP
$197B
$92.8M 0.22%
562,428
+9,122
+2% +$1.57M
NFE icon
111
New Fortress Energy
NFE
$94.8M
$91.9M 0.22%
4,182,200
-217,800
-5% -$5.63M
PANW icon
112
Palo Alto Networks
PANW
$257B
$90.9M 0.22%
536,500
-88,564
-14% -$13.2M
DASH icon
113
DoorDash
DASH
$85.2B
$90.7M 0.21%
833,361
+81,905
+11% +$9.87M
CLH icon
114
Clean Harbors
CLH
$17.1B
$88.7M 0.21%
392,190
+5,008
+1% +$1.05M
CB icon
115
Chubb
CB
$142B
$88.5M 0.21%
346,803
-63,607
-15% -$16.3M
RCL icon
116
Royal Caribbean
RCL
$85.9B
$88.4M 0.21%
554,257
-60,114
-10% -$8.64M
RARE icon
117
Ultragenyx Pharmaceutical
RARE
$2.5B
$86.6M 0.21%
2,107,025
+168,345
+9% +$7.19M
RGA icon
118
Reinsurance Group of America
RGA
$15.7B
$86.5M 0.21%
421,585
-31,001
-7% -$6.19M
CRM icon
119
Salesforce
CRM
$152B
$85.6M 0.2%
332,904
-77,978
-19% -$20.9M
GMS
120
DELISTED
GMS Inc
GMS
$85.1M 0.2%
1,056,053
+9,516
+0.9% +$878K
ATR icon
121
AptarGroup
ATR
$8.65B
$84.8M 0.2%
602,175
-7,070
-1% -$1.02M
VRSK icon
122
Verisk Analytics
VRSK
$28.7B
$84.7M 0.2%
314,232
-15,302
-5% -$3.74M
ARES icon
123
Ares Management
ARES
$28B
$83.3M 0.2%
625,000
BSX icon
124
Boston Scientific
BSX
$68.4B
$83.3M 0.2%
1,081,229
+704,464
+187% +$51.6M
PAYC icon
125
Paycom
PAYC
$7.96B
$83.2M 0.2%
581,964
+529,591
+1,011% +$90.8M

Similar funds

Federated Hermes's Q2 2024 Portfolio in Review

As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
  • Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
  • Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
  • Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
  • Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
  • Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.